These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 19273707

  • 1. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
    Carrie C, Grill J, Figarella-Branger D, Bernier V, Padovani L, Habrand JL, Benhassel M, Mege M, Mahé M, Quetin P, Maire JP, Baron MH, Clavere P, Chapet S, Maingon P, Alapetite C, Claude L, Laprie A, Dussart S.
    J Clin Oncol; 2009 Apr 10; 27(11):1879-83. PubMed ID: 19273707
    [Abstract] [Full Text] [Related]

  • 2. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.
    Carrie C, Muracciole X, Gomez F, Habrand JL, Benhassel M, Mege M, Mahé M, Quetin P, Maire JP, Soum F, Baron MH, Clavere P, Chapet S, Gaci Z, Kolodie H, Maingon P, Vie B, Bernier V, Alapetite C, Hoffstetter S, Grill J, Lafay F, French Society of Pediatric Oncology.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):711-6. PubMed ID: 15927408
    [Abstract] [Full Text] [Related]

  • 3. Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy.
    Gupta T, Jalali R, Goswami S, Nair V, Moiyadi A, Epari S, Sarin R.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1534-40. PubMed ID: 22342098
    [Abstract] [Full Text] [Related]

  • 4. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
    Carrie C, Kieffer V, Figarella-Branger D, Masliah-Planchon J, Bolle S, Bernier V, Laprie A, Supiot S, Leseur J, Habrand JL, Alapetite C, Kerr C, Dufour C, Claude L, Chapet S, Huchet A, Bondiau PY, Escande A, Truc G, Nguyen TD, Pasteuris C, Vigneron C, Muracciole X, Bourdeaut F, Appay R, Dubray B, Colin C, Ferlay C, Dussart S, Chabaud S, Padovani L, French Group of Pediatric Radiotherapy (GFRP), French Society of Pediatric Cancers (SFCE).
    Int J Radiat Oncol Biol Phys; 2020 Dec 01; 108(5):1204-1217. PubMed ID: 32768563
    [Abstract] [Full Text] [Related]

  • 5. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
    Douglas JG, Barker JL, Ellenbogen RG, Geyer JR.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1161-4. PubMed ID: 15001259
    [Abstract] [Full Text] [Related]

  • 6. Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma.
    Wolden SL, Dunkel IJ, Souweidane MM, Happersett L, Khakoo Y, Schupak K, Lyden D, Leibel SA.
    J Clin Oncol; 2003 Aug 15; 21(16):3079-83. PubMed ID: 12915597
    [Abstract] [Full Text] [Related]

  • 7. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R.
    J Clin Oncol; 2006 Sep 01; 24(25):4202-8. PubMed ID: 16943538
    [Abstract] [Full Text] [Related]

  • 8. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P, Pavelka Z, Dusek L, Hynkova L, Sterba J, Ondrova B, Princ D, Novotny T, Kostakova S.
    Neoplasma; 2007 Sep 01; 54(1):62-7. PubMed ID: 17203894
    [Abstract] [Full Text] [Related]

  • 9. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
    Polkinghorn WR, Dunkel IJ, Souweidane MM, Khakoo Y, Lyden DC, Gilheeney SW, Becher OJ, Budnick AS, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):e15-20. PubMed ID: 21481547
    [Abstract] [Full Text] [Related]

  • 10. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
    Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A.
    J Clin Oncol; 2005 Aug 20; 23(24):5511-9. PubMed ID: 16110011
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors.
    Kieffer-Renaux V, Viguier D, Raquin MA, Laurent-Vannier A, Habrand JL, Dellatolas G, Kalifa C, Hartmann O, Grill J.
    Pediatr Blood Cancer; 2005 Nov 20; 45(6):814-9. PubMed ID: 15924360
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique.
    Bouffet E, Baranzelli MC, Patte C, Portas M, Edan C, Chastagner P, Mechinaud-Lacroix F, Kalifa C.
    Br J Cancer; 1999 Mar 20; 79(7-8):1199-204. PubMed ID: 10098759
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M, Chintagumpala M, Laningham FH, Ashley D, Kellie SJ, Langston JW, McCluggage CW, Woo S, Kocak M, Krull K, Kun LE, Mulhern RK, Gajjar A.
    J Clin Oncol; 2004 Nov 15; 22(22):4551-60. PubMed ID: 15542806
    [Abstract] [Full Text] [Related]

  • 15. Craniospinal radiotherapy in adult medulloblastoma.
    Selek U, Zorlu F, Hurmuz P, Cengiz M, Turker A, Soylemezoglu F, Gurkaynak M.
    Strahlenther Onkol; 2007 May 15; 183(5):236-40. PubMed ID: 17497094
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley DM, Sexton M, Kellie SJ, Ahern V, Gajjar A.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):782-7. PubMed ID: 17892918
    [Abstract] [Full Text] [Related]

  • 19. Radiation treatment for medulloblastoma: a review of 64 cases at a single institute.
    Liu Y, Zhu Y, Gao L, Xu G, Yi J, Liu X, Li Y.
    Jpn J Clin Oncol; 2005 Mar 01; 35(3):111-5. PubMed ID: 15741299
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.